期刊文献+

地塞米松对顺铂诱导中国人肺腺癌原代细胞凋亡的影响 被引量:4

Effect of Dexamethasone on Cisplatin Induced Apoptosis in Primary Cells from Resected Specimens with Chinese Human Lung Adenocarcinoma ex vivo
下载PDF
导出
摘要 背景与目的糖皮质激素如地塞米松能诱导淋巴细胞的凋亡并能防治因化疗引发的恶心及呕吐。然而,最近的研究资料显示糖皮质激素能引发欧洲人肺癌治疗耐药。中国人肺腺癌化疗时地塞米松对顺铂抑制肺腺癌原代细胞增殖效应的影响,目前尚不清楚。方法分离10例经病理学确诊为中国人源肺腺癌的原代细胞,经不同浓度的顺铂+/-地塞米松处理,采用四氮唑蓝比色法(MTT)检测肺腺癌原代细胞的增殖状况,并应用流式细胞仪检测顺铂联合地塞米松处理后的人肺腺癌细胞株A549的细胞凋亡率。结果在10例肺腺癌原代细胞中,地塞米松均可降低顺铂抑制肺腺癌原代细胞增殖的效应。同样,人肺腺癌细胞株A549,经顺铂联合地塞米松培养2周和3周后,地塞米松能降低癌细胞因顺铂诱导的细胞死亡率和凋亡率,提示地塞米松对顺铂诱导的细胞凋亡有抑制效应。结论地塞米松可以降低顺铂诱导肺腺癌细胞凋亡的作用,建议在肺腺癌化疗时谨慎使用地塞米松。 Background and objective Glucocorticoids, such as dexamethasone (DEX), have been widely used in conjunction with cancer therapy due to inducing apoptosis in lymphoid cells and preventing nausea and vomiting. However, recent research indicates induction of therapy-resistance by glucocorticoids in lung cancer in European, although it is unclear whether DEX mediates the resistance of cisplatin-induced apoptosis in primary cells from resected Chinese human lung adeno- carcinoma specimens. Methods Ten primary cells from resected Chinese human lung adenocarcinoma specimens were treated with cisplatin in the presence or absence of DEX. The number of viable and dead cells was evaluated by trypan blue exclusion; the cell proliferation was measured by the MTT-assay; the cell apoptotic rate was analyzed by flow cytometry. Results In this study, it was found that DEX reduced the effect of cisplatin-induced proliferation inhibition in all of the primary cells from 10 examined tumor samples. On the other hand, the cell death and apoptosis induced by cisplatin in human lung adenocarcinoma ceils line A549 could also be inhibited in the presence of DEX during 2 and 3 weeks' co-incubation. Conclusion DEX may reduce the effect of chemotherapy with cisplatin, and it urges carefully reconsideration of the application of DEX in treatment of patients with lung adenocarcinoma in China.
出处 《中国肺癌杂志》 CAS 2010年第1期28-33,共6页 Chinese Journal of Lung Cancer
基金 浙江省自然科学基金(No.Y207802) 浙江省钱江人才资助基金(No.2007R10032) 嘉兴市科技计划项目基金(No.2007AY2034)资助~~
关键词 肺肿瘤 顺铂 地塞米松 Lung neoplasms Cisplatin Dexamethasone
  • 相关文献

参考文献17

  • 1Levi F, Lucchini F, Negri E, et al. Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. IntJ Cancer, 2004,110(2): 155-169. 被引量:1
  • 2Office for National Statistics. Living in britain: preliminary results from the 1996 general household survey. In: Office for National Statistics. London: the Stationery Office, 1997.75-79. 被引量:1
  • 3Meschini S, Marra M, Calcabrini A. Role of he lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cell. Toxicol in vitro, 2002, 16(4): 389-398. 被引量:1
  • 4Tsavaris N, Kosmas C, Vadiaka M, et al. Ondansentron and dexamethasone treatment with different dosing schedules (24 versus 32 mg) in patients with non-small-cell lung cancer under cisplatin-based chemotherapy: a randomized study. Chemotherapy, 2000, 46(5): 364-370. 被引量:1
  • 5Chen Y, Nickola T, DiFronzo N, et al. Dexamethasone-mecllated repression of MUCSAC gene expression in human lung epithelial cells. Cell Mol Biol, 2006, 34(3): 338-347. 被引量:1
  • 6Herr I, Ucur E, Herzer K, et al. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Cancer Res, 2003, 63(12): 3112-3120. 被引量:1
  • 7Gassier N, Zhang C, Wenger T, et al. Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo. BrJ Cancer, 2005, 92(6): 1084-1088. 被引量:1
  • 8Rutz HP. Effects of corticosteroid use on treatment of solid tumours. Lancet, 2002, 360(9349): 1969-1970. 被引量:1
  • 9Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene, 2003, 22(47): 7265-7279. 被引量:1
  • 10Yoshimura N, Kudoh S, Mukohara T, et al. Phase Ⅰ/Ⅱ study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer. Br J Cancer, 2004, 90(6): 1184-1189. 被引量:1

二级参考文献48

  • 1Harris AL. Hypoxia-a key regulatory factor in tumour growth.Nat Rev Cancer,2002,2(1) : 38-47. 被引量:1
  • 2Kaelin WG Jr. How oxygen makes its presence felt. Genes Dev,2002,16(12):1441-1445. 被引量:1
  • 3Nauck M, Karakiulakis G, Perruchoud AP, et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol, 19980341(2-3):309-315. 被引量:1
  • 4Machein MR, Kullmer J, Ronicke V, et al. Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathol Appl Neurobiol,1999,25(2):104-112. 被引量:1
  • 5Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia inducible factor 1alpha in common human cancers and their metastases. Cancer Res,1999,59(22) : 5830-5835. 被引量:1
  • 6Zagzag D, Zhong H, Scalzitti JM, et al. Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer,2000,88(11) : 2606-2618. 被引量:1
  • 7Wang GL, Semenza GL. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem, 1993,268(29) : 21513-21518. 被引量:1
  • 8Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J, 1999,13(1):9-22. 被引量:1
  • 9Liu Y, Cox SR, Morita T, et al. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res, 1995,77(3) : 638-643. 被引量:1
  • 10Liu LX, Lu H, Luo Y, et al. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1. Biochem Biophys Res Commun,2002,291(4) : 908-914. 被引量:1

共引文献5

同被引文献32

  • 1朱君荣,孙建国,谢海棠,娄晟,陶宜富,肖大伟,王广基.人参皂苷-Rh_2对人乳腺癌T47D细胞的生长抑制作用及对Caspase-3表达的影响[J].中国临床药理学与治疗学,2007,12(6):630-634. 被引量:8
  • 2Meschini S, Marra M, Calcabrini A.Role of he lung resist- ance-related protein (LRP) in the drug sensitivity of cul- tured tumor cell [ J ]. Toxicol in vitro, 2002, 16 (4) : 389- 398. 被引量:1
  • 3Gassler N, Zhang C, Wenger T, et al.Dexamethasone-in- duced cisplatin and gemeitabine resistance in lung carci- noma samples treated ex vivo [ J 1. Br J Cancer, 2005,92 (6) :1084-1088. 被引量:1
  • 4Chen YX, Wang Y, Fu CC, et al.Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells [ J .En- docr relat. Cancer,2010,17( 1 ) :39-50. 被引量:1
  • 5Haiyan Ge,Songshi Ni, Xingan Wang, et al. Dexametha- sone Reduces Sensitivity to Cisplatin by Blunting Caspase -12-Dependent Cellular Senescence in Non-Small Cell Lung Cancer[ J] .PLOS ONE ,2012,7(12) :e51 821. 被引量:1
  • 6Niida H, Nakanishi M. DNA damage checkpoints in mam- mals [ J 1. Mutagenesis, 2006,21 ( 1 ) : 3- 9. 被引量:1
  • 7刘特,黄文彬,赖冬梅,等.姜黄素对人脑胶质瘤细胞凋亡作用及其对Bel-2与Caspase8诱导表达的影响[J].2009,19(4):247-251. 被引量:1
  • 8Wu W, Chaudhuri S, Brickley DR, et al. Microarray analysis re- veals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells [J]. Cancer Res,2004, 64(5) : 1757-1764. 被引量:1
  • 9Zhang C, Mattem J, Haferkamp A, et al. Corticosteroid-indueed chemotherapy resistance in urological cancers[J]. Cancer Biol Ther, 2006,5 ( 1 ) : 59-64. 被引量:1
  • 10Yoshida Y, Kishimoto T, Ishiguro H, et al. Dexamethasone modi- fies the susceptibility to serum cytotoxicity and increases the me- tastatic efficiency of a colon carcinoma cell line[J]. Exp Mol Pathol, 2006,81 ( 1 ) : 77-84. 被引量:1

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部